Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Januar 2024 08:30 ET | Quelle: Elevai Labs Inc.

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
17. Januar 2024 08:30 ET | Quelle: Elevai Labs Inc.

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

ELEVAI Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
16. Januar 2024 08:30 ET | Quelle: Elevai Labs Inc.

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
02. Januar 2024 09:15 ET | Quelle: Elevai Labs Inc.

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
11. Dezember 2023 09:15 ET | Quelle: Elevai Labs Inc.

Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023

Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
07. Dezember 2023 09:41 ET | Quelle: Elevai Labs Inc.

ELEVAI Labs, Inc. Expands International Distribution into Europe

ELEVAI Labs, Inc. Expands International Distribution into Europe
29. November 2023 09:00 ET | Quelle: Elevai Labs Inc.

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences

Vorherige Seite